Artykuły udostępnione publicznie: - John P. SeibylWięcej informacji
Niedostępne w żadnym miejscu: 5
Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction
M Brendel, M Högenauer, A Delker, J Sauerbeck, P Bartenstein, J Seibyl, ...
Neuroimage 108, 450-459, 2015
Upoważnienia: US National Institutes of Health, Canadian Institutes of Health Research
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
KT Ong, VL Villemagne, A Bahar-Fuchs, F Lamb, N Langdon, AM Catafau, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (4), 431-436, 2015
Upoważnienia: National Health and Medical Research Council, Australia
Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden
J Blautzik, M Brendel, J Sauerbeck, S Kotz, F Scheiwein, P Bartenstein, ...
European journal of nuclear medicine and molecular imaging 44, 1364-1374, 2017
Upoważnienia: US Department of Defense, US National Institutes of Health, Canadian …
Parkinson's Progression Markers Initiative brain autopsy program
SA Bukhari, KNH Nudelman, M Rumbaugh, P Richeson, EJ Fox, ...
Parkinsonism & Related Disorders 101, 62-65, 2022
Upoważnienia: Michael J Fox Foundation
Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with 123I‐INER
AA Dos Santos Tavares, O Barret, J Batis, D Alagille, A Koren, C Papin, ...
Synapse 67 (1), 30-41, 2013
Upoważnienia: Chief Scientist Office, Scottish Executive
Dostępne w jakimś miejscu: 96
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
Upoważnienia: US National Institutes of Health
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts
O Hansson, J Seibyl, E Stomrud, H Zetterberg, JQ Trojanowski, T Bittner, ...
Alzheimer's & dementia 14 (11), 1470-1481, 2018
Upoważnienia: US National Institutes of Health, UK Medical Research Council
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson …
JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ...
JAMA neurology 70 (10), 2013
Upoważnienia: US National Institutes of Health
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
A Siderowf, L Concha-Marambio, DE Lafontant, CM Farris, Y Ma, ...
The Lancet Neurology 22 (5), 407-417, 2023
Upoważnienia: US National Institutes of Health, Michael J Fox Foundation, Aligning Science …
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
T Simuni, LM Chahine, K Poston, M Brumm, T Buracchio, M Campbell, ...
The Lancet Neurology 23 (2), 178-190, 2024
Upoważnienia: US National Institutes of Health, Parkinson's UK, Michael J Fox Foundation …
Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease
Z Qamhawi, D Towey, B Shah, G Pagano, J Seibyl, K Marek, ...
Brain 138 (10), 2964-2973, 2015
Upoważnienia: UK Medical Research Council
Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy
M Brendel, H Barthel, T van Eimeren, K Marek, L Beyer, M Song, C Palleis, ...
JAMA neurology 77 (11), 1408-1419, 2020
Upoważnienia: German Research Foundation, Federal Ministry of Education and Research, Germany
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ...
European journal of nuclear medicine and molecular imaging 47, 1885-1912, 2020
Upoważnienia: US National Institutes of Health
Conversion to Parkinson disease in the PARS hyposmic and dopamine transporter–deficit prodromal cohort
D Jennings, A Siderowf, M Stern, J Seibyl, S Eberly, D Oakes, K Marek, ...
JAMA neurology 74 (8), 933-940, 2017
Upoważnienia: US Department of Defense
Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort
T Simuni, A Siderowf, S Lasch, CS Coffey, C Caspell‐Garcia, D Jennings, ...
Movement Disorders 33 (5), 771-782, 2018
Upoważnienia: US Department of Defense, US National Institutes of Health, US Department of …
β2-nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking
KP Cosgrove, J Batis, F Bois, PK Maciejewski, I Esterlis, T Kloczynski, ...
Archives of general psychiatry 66 (6), 666-676, 2009
Upoważnienia: US National Institutes of Health
Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression
B Mollenhauer, M Dakna, N Kruse, D Galasko, T Foroud, H Zetterberg, ...
Movement Disorders 35 (11), 1999-2008, 2020
Upoważnienia: US National Institutes of Health, German Research Foundation, European …
Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury
EM Mitsis, S Riggio, L Kostakoglu, DL Dickstein, J Machac, B Delman, ...
Translational psychiatry 4 (9), e441-e441, 2014
Upoważnienia: US National Institutes of Health
Persistent β2*-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
A Saricicek, I Esterlis, KH Maloney, YS Mineur, BM Ruf, A Muralidharan, ...
American Journal of Psychiatry 169 (8), 851-859, 2012
Upoważnienia: US National Institutes of Health
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
B Mollenhauer, CJ Caspell-Garcia, CS Coffey, P Taylor, LM Shaw, ...
Neurology 89 (19), 1959-1969, 2017
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy